[A comparative placebo-controlled clinical study on the efficacy and safety of interferon beta-1a for subcutaneous injections in patients with remitting multiple sclerosis: results of the first year of observations]. [electronic resource]
- Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova
- 107-113 p. digital